Eve Namisango
ID: UNCST-2021-R014038
|
Improving end-of-life care for dying patients and their families in Ugandan ICUs
REFNo: HS4832ES
5. Synthesise the findings to produce recommendations for future end-of-life care in ICU practice, research and policy.,To explore clinicians’ experiences of end-of-life care provision in Ugandan ICUs and the use of person-centred outcome measures.,3. To utilise the Integrated Palliative care Outcome Scale (IPOS) staff version as a tool in identifying symptoms and important concerns at the end of life in ICU,2. To assess symptoms and important concerns at end=of-life in ICU using the integrated palliative care outcome scale ,1. To explore ICU clinician’s perspectives of factors influencing the provision of quality end-of-life care through a survey,To explore factors influencing the provision of end-of-life care in Ugandan ICUs test and evaluate the use of person-centred outcome measures in improving end-of-life care in dying patients and their families,
|
Uganda |
2024-11-26 19:41:46 |
2027-11-26 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Fred Nalugoda
ID: UNCST-2021-R013343
|
Improving understanding of Capacity to consent to sensitive biomedical Research among adolescents in Rakai Uganda (ICARE)
REFNo: SS3447ES
Aim 1: Sampling from RCCS-experienced and RCCS-naïve households, and using the MacCAT-CR, examine adolescent capacity to consent to biomedical research and correlates of that capacity.
1.a: Compare capacity to consent among early, middle, and late adolescents and their guardians.
1.b: Assess correlates of capacity, including actionable factors such as health literacy and education and biomedical-related factors such as PrEP eligibility, use, awareness, beliefs, peer norms, and stigma.
Aim 2: Using a systematic qualitative analysis – guided by our conceptual framework for mapping age differences – examine processes of decision-making around biomedical prevention and biomedical research (e.g., stigma, understanding of biomedical prevention and research risks and benefits and constructs like randomization, privacy, safety and autonomy) among guardians and early, middle and late adolescents.
Aim 3: In partnership with US and Uganda researchers, and IRB members, construct a digital toolkit to support decision making regarding key aspects of minor consent in low-resource settings.
|
Uganda |
2024-11-26 19:40:05 |
2027-11-26 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Jacklyn Arinaitwe Makaaru
ID: UNCST-2024-R015354
|
Examining the combined effects of a two-generation model involving childcare and financial support interventions to vulnerable businesswomen in urban refugee and host communities in Kampala
REFNo: SS3367ES
i) To understand the status of childcare burden and its attendant constraints on livelihoods for urban refugee women.
ii) To design interventions that alleviate the childcare burden for urban refugee women while at the same time improving their social and economic welfare.
iii) To evaluate the effects of these interventions on reducing the burden of childcare as well as business growth, productivity, profitability, livelihoods, and the wellbeing of urban refugee women/caregivers.
|
Uganda |
2024-11-25 17:30:05 |
2027-11-25 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Edgar Mulogo Mugema
ID: UNCST-2023-R008170
|
Viral causes of acute respiratory illness among hospitalized children in Kasese District, Uganda:an observational cohort study.
REFNo: HS5218ES
Primary Objectives
The primary objective of this study is to test the feasibility of implementing rapid molecular diagnostic test and assess the burden and epidemiology of influenza subtypes A and B, SARS- CoV-2, and RSV among pediatric patients hospitalized for ARI in Kasese District, Uganda.
Specific Aims
Determine the feasibility of implementing a rapid molecular diagnostic testing program at peripheral health centers in rural western Uganda. We will measure the number of eligible children consenting to testing, the number of tests performed, the median time from sample collection to result, and the number of invalid test results due to either operator error or equipment issues.
Measure the proportion of pediatric hospitalizations for ARI attributable to SARS-CoV-2, influenza subtype A and B, and RSV in communities with different population densities in Kasese district. We will enroll children admitted with ARI, test a nasopharyngeal swab for influenza, SARS-CoV-
2 and RSV using the Cepheid GeneXpert platform, and document participant demographic information.
Describe the clinical presentation and management for patients admitted with respiratory illness to health facilities in Kasese District. We will record the vaccination history, presenting symptoms, diagnoses, and treatments administered, including antibiotics. We will also follow-up all enrolled participants two weeks after admission to determine illness outcomes. We will compare these variables between those who test positive and those who test negative for SARS-CoV-2, influenza, and RSV.
|
Uganda |
2024-11-25 17:28:46 |
2027-11-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
JULIET BABIRYE ALLEN
ID: UNCST-2023-R005641
|
PREVALENCE AND ASSOCIATED FACTORS OF DYSLIPIDEMIAS AMONG PLHIV AT GOMBE HOSPITAL, IN RURAL UGANDA
REFNo: HS5050ES
ii. To determine the factors associated with dyslipidemia among PLHIV in rural Uganda.,i. To determine the prevalence of dyslipidemia among PLHIV in rural Uganda,To determine the prevalence of dyslipidemia and the associated factors among PLHIV attending the HIV clinic at Gombe hospital.,
|
Uganda |
2024-11-25 17:25:45 |
2027-11-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|